Steven Kesten - Net Worth and Insider Trading

Steven Kesten Net Worth

The estimated net worth of Steven Kesten is at least $2 dollars as of 2024-05-06. Steven Kesten is the Exec VP and Chief MO of Plus Therapeutics Inc and owns about 1 shares of Plus Therapeutics Inc (PSTV) stock worth over $2. Details can be seen in Steven Kesten's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Steven Kesten has not made any transactions after 2015-08-19 and currently still holds the listed stock(s).

Transaction Summary of Steven Kesten

To

Steven Kesten Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Steven Kesten owns 1 companies in total, including Plus Therapeutics Inc (PSTV) .

Click here to see the complete history of Steven Kesten’s form 4 insider trades.

Insider Ownership Summary of Steven Kesten

Ticker Comapny Transaction Date Type of Owner
PSTV Plus Therapeutics Inc 2015-08-19 Exec VP and Chief MO

Steven Kesten Latest Holdings Summary

Steven Kesten currently owns a total of 1 stock. Steven Kesten owns 1 shares of Plus Therapeutics Inc (PSTV) as of August 19, 2015, with a value of $2.

Latest Holdings of Steven Kesten

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PSTV Plus Therapeutics Inc 2015-08-19 1 1.90 2

Holding Weightings of Steven Kesten


Steven Kesten Form 4 Trading Tracker

According to the SEC Form 4 filings, Steven Kesten has made a total of 0 transactions in Plus Therapeutics Inc (PSTV) over the past 5 years. The most-recent trade in Plus Therapeutics Inc is the acquisition of 1 shares on August 19, 2015, which cost Steven Kesten around $2,340.

Insider Trading History of Steven Kesten

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Steven Kesten Trading Performance

GuruFocus tracks the stock performance after each of Steven Kesten's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven Kesten is -13.92%. GuruFocus also compares Steven Kesten's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven Kesten within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Steven Kesten's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Steven Kesten

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.8
Relative Return to S&P 500(%) 9.65

Steven Kesten Ownership Network

Ownership Network List of Steven Kesten

No Data

Ownership Network Relation of Steven Kesten


Steven Kesten Owned Company Details

What does Plus Therapeutics Inc do?

Who are the key executives at Plus Therapeutics Inc?

Steven Kesten is the Exec VP and Chief MO of Plus Therapeutics Inc. Other key executives at Plus Therapeutics Inc include President Marc H Hedrick , Chief Financial Officer Sims Andrew John Hugh Macintyre , and CHIEF MEDICAL OFFICER Norman D. Lafrance .

Plus Therapeutics Inc (PSTV) Insider Trades Summary

Over the past 18 months, Steven Kesten made no insider transaction in Plus Therapeutics Inc (PSTV). Other recent insider transactions involving Plus Therapeutics Inc (PSTV) include a net purchase of 23,094 shares made by Robert P Lenk , a net purchase of 10,493 shares made by Howard Clowes , and a net purchase of 20,000 shares made by Greg Petersen .

In summary, during the past 3 months, insiders sold 0 shares of Plus Therapeutics Inc (PSTV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,568 shares of Plus Therapeutics Inc (PSTV) were sold and 55,087 shares were bought by its insiders, resulting in a net purchase of 51,519 shares.

Plus Therapeutics Inc (PSTV)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Plus Therapeutics Inc Insider Transactions

No Available Data

Steven Kesten Mailing Address

Above is the net worth, insider trading, and ownership report for Steven Kesten. You might contact Steven Kesten via mailing address: 3020 Callan Road, San Diego Ca 92121.

Discussions on Steven Kesten

No discussions yet.